Welcome to our dedicated page for BRASKEM SA SEC filings (Ticker: BAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BRASKEM SA's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BRASKEM SA's regulatory disclosures and financial reporting.
Braskem S.A. reports that the Tribunal of Brazil’s competition authority CADE has unanimously and unconditionally approved Concentration Act No. 08700.006808/2025-81, which was jointly submitted by NSP Investimentos S.A. and Petroquímica Verde Fundo de Investimento em Participações – Multistrategy. The correspondence from Novonor S.A. – Under Judicial Reorganization emphasizes that the terms and conditions reviewed by CADE are not definitive or binding for any potential transaction, and that negotiations between NSP Investimentos and the Fund are still ongoing and may lead to different terms. Braskem states it will keep shareholders and the market informed of any material developments related to this matter in line with applicable laws.
Braskem S.A. reported that credit rating agencies Fitch Ratings and S&P Global Ratings have lowered its global-scale corporate credit ratings to CCC+ and CCC-, respectively, both with a negative outlook. These ratings signal that the agencies see Braskem as highly vulnerable to adverse business or financial conditions.
The Company states that it remains committed to its stakeholders and is focused on resilience and transformation initiatives to address the prolonged global downturn affecting the chemical industry and to strengthen the competitiveness of the Brazilian chemical sector. Management also reiterates that forward-looking statements are subject to significant risks and uncertainties, including industry conditions, legal matters in Alagoas and broader economic factors.
Braskem S.A. filed a Form 6-K to disclose the internal rules of its Strategy, Communication & ESG Committee, a permanent advisory body to the Board of Directors. The committee supports the Board on strategy, disclosure of information, sustainable development and health, safety, environment, quality and productivity topics. It is composed of three to five directors appointed by the Board chair, with two-year terms that match the Board’s mandate and one member serving as coordinator.
The rules describe how the committee operates, including at least four ordinary meetings per year, preferred timing before Board meetings, quorum requirements, remote participation procedures and strict confidentiality obligations. They also address how conflicts of interest are handled and state that, in any inconsistency, the Company’s Bylaws prevail. The Board approved these internal rules on September 25, 2025, and they will be made available on Braskem’s website.
Braskem S.A. filed a Form 6-K describing the internal rules of its People and Organization Committee, a permanent advisory body to the Board of Directors. The committee supports the board on personnel-related policies, including compensation and occupational health, and monitors strategic projects related to people. It is composed of three to five board members appointed by the chairman, with two-year terms aligned to their board mandates and one member serving as coordinator. The rules detail meeting frequency of at least four times per year, quorum, advance distribution of materials, and the possibility of remote participation, while emphasizing confidentiality. They also set out conflict-of-interest procedures, give the Corporate Governance and Secretariat areas support roles, and state that the company’s bylaws prevail over these rules if inconsistencies arise. The rules were approved at a board meeting held on September 25, 2025.
Braskem S.A. submitted a Form 6-K describing updated internal rules for its Finance and Investment Committee, a permanent body that supports the Board of Directors on financial matters, investments, dividends, securities trading and collateral decisions. The rules require members to follow Brazilian corporate law, securities regulations, the shareholders’ agreement, the bylaws and duties of loyalty, diligence and confidentiality.
The Committee will have between three and five Board members, appointed for terms that match their Board mandates, with one acting as coordinator. It must meet at least quarterly, ordinarily before Board meetings, with materials generally sent seven days in advance. Meetings may be held in person or remotely, with strict information security and confidentiality requirements.
The rules set procedures for quorum, minute-taking and publication of recommendations on Braskem’s governance website. They also address how conflicts of interest are identified and handled, including restricting conflicted members from deliberations and, when necessary, limiting their access to related information. The Board of Directors approved these internal rules on September 25, 2025.
Braskem S.A. governance fragment describes board and committee procedures focused on risk oversight, meeting protocols and director onboarding. It requires the board to approve the annual Global Corporate Risk Map, the annual internal audit plan, and scales for risk impact and probability when relevant changes occur. It defines the composition and invitation rules for committee (RCA) meetings, notes use of external consultants when necessary, and mandates minutes, filing and publication consistent with applicable law. The text also covers conflict-of-interest handling, executive sessions, and a structured onboarding program for new directors to receive required information, meet executives, and attend compliance training.
Braskem S.A. discloses portions of its Corporate Compliance and Audit Committee (CCAE) charter in this Form 6-K. The document lists the CCAE's objectives and duties focused on oversight of the company’s compliance system, internal controls, internal audit, risk management and related-party matters. It references alignment with applicable global practices and requires the CCAE to review the annual internal audit plan before Board deliberation and to monitor the Global Corporate Risk Map. The charter mandates independence criteria consistent with CVM Resolution No. 23/21 and sets meeting procedures, including a minimum notice period of 48 hours when shorter deadlines apply. Other sections (member qualifications, specific duties, and procedures) are present but substantially redacted or truncated in the provided text.
Braskem S.A. filed a report stating that it has hired financial and legal advisors to help prepare an assessment of economic and financial alternatives to optimize its capital structure. This means the company is formally studying different ways to adjust how it is financed, such as its mix of debt and equity, to better support its business.
The company highlights a prolonged downturn affecting the entire chemical industry and says it remains focused on transformation initiatives to reduce these impacts and strengthen the competitiveness of the Brazilian chemical sector. Braskem states it will keep shareholders and the market informed of any material developments related to this capital structure review.
Braskem S.A. filed an amended Form 6-K presenting the 3rd version of its 2025 annual calendar of corporate events. The company plans to release quarterly financial statements for the first quarter on 05/09/2025, the second quarter on 08/06/2025, and the third quarter on 11/10/2025.
For its annual shareholders’ meeting cycle, Braskem schedules submission of the management proposal and call notice for 03/28/2025, the annual shareholders’ meeting itself on 04/28/2025, and submission of the meeting minutes also on 04/28/2025. A public meeting with analysts is indicated as “to be defined” for 12/01/2025.
The filing includes a standard forward-looking statement disclaimer, noting that statements about future performance, the impact of the geological event in Alagoas, related legal proceedings, and COVID-19 involve risks and uncertainties and may differ materially from current expectations.
Braskem S.A. reports that S&P Global Ratings has revised its global corporate credit rating to B+ with a Negative Outlook. This signals that the agency sees higher risk around the company’s credit profile going forward. Braskem explains that it is concentrating on “resilience initiatives” to offset the impact of a prolonged downturn in the global petrochemical cycle and to reinforce the competitiveness of the Brazilian chemical industry.